Nektar Therapeutics's total assets for Q4 2025 were $280.41M, a decrease of -6.95% from the previous quarter. NKTR total liabilities were $190.57M for the fiscal quarter, a -11.88% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.